Home
Archives
Contact

✕

Blog

Home
Blog

✕

FIND US

CATEGORIES

Editorials
New Trials
Ongoing Trials
Trial Results

LATEST POSTS

0
Using AI in research to assess breast cancer recurrence risk
February 11, 2026
0
Now Enrolling: The EA1241 research study is exploring why breast cancer can come back years later
February 11, 2026

RECENT COMMENTS

November 11, 2025
Beating the odds: Steven Merlin’s journey through pancreatic cancer and clinical trials- Ecog-Acrin - Seena Magowitz Foundation commented on Beating the odds: Steven Merlin’s journey through pancreatic cancer and clinical trials
July 29, 2025
ECOG-ACRIN Staff commented on Ongoing Trial: Clinical trial EA5182 is testing the addition of a drug to the most commonly used first treatment for patients with lung cancer that has spread

TAGS

Advocacy Anal cancer Artificial intelligence (AI) Bladder cancer Brain cancer Breast cancer Colorectal cancer ComboMATCH Esophagus cancer Gallbladder cancer Head and neck cancer Health equity Immunotherapy In memory Kidney cancer Leukemia Liver cancer Lung cancer Lymphoma Mammography Melanoma Myelodysplastic syndrome Myeloma NCI-MATCH Older adults Pancreatic cancer Pancreatic cysts Patient-reported outcomes Patient education Patient navigation Penis cancer Personalized treatment Policy Precision medicine Prevention Prostate cancer Real-world data/evidence Research results Sarcoma Screening for cancer Side effects Survivorship Targeted therapy Upper tract urothelial cancer Young adults

Office of Communications
1818 Market Street, Suite 3000
Philadelphia, PA 19103
Phone: 215.789.3631
www.ecog-acrin.org

Contact us with any questions

© 2019-2026 ECOG-ACRIN Cancer Research Group. All Rights Reserved. Designed by Create & Associates, Inc